Literature DB >> 11955025

Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test?

Michael P Stern1, Ken Williams, Steven M Haffner.   

Abstract

BACKGROUND: The standard method of identifying persons at high risk for type 2 diabetes mellitus involves detection of impaired glucose tolerance, which requires a costly and inconvenient 2-hour oral glucose tolerance test. Because clinical trials have indicated that diabetes is preventable by using behavioral or pharmacologic interventions, less expensive methods of identifying high-risk persons are needed.
OBJECTIVE: To determine whether multivariable models are superior to glucose tolerance tests for identifying persons at high risk for diabetes mellitus.
DESIGN: Prospective cohort study.
SETTING: San Antonio, Texas. PARTICIPANTS: 1791 Mexican Americans and 1112 non-Hispanic whites without diabetes at baseline who were randomly selected from census tracts. MEASUREMENTS: Medical history; body mass index; blood pressure; fasting and 2-hour plasma glucose levels; fasting serum total, low-density lipoprotein, and high-density lipoprotein cholesterol levels; and triglyceride level.
RESULTS: For prediction of 7.5-year incidence of type 2 diabetes, the area under the receiver-operating characteristic (ROC) curve for a multivariable model involving readily available clinical variables was significantly (P < 0.001) greater than the area under the ROC curve for the 2-hour glucose value alone (84.3% vs. 77.5%). Impaired glucose tolerance represents a single point on the latter curve. Adding the 2-hour glucose measurement to the multivariable model increased the area under its ROC curve, but only from 84.3% to 85.7%.
CONCLUSION: Persons at high risk for diabetes mellitus are better identified by using a simple prediction model than by relying exclusively on the results of a 2-hour oral glucose tolerance test. Although adding the 2-hour glucose variable to the model enhanced prediction, the resulting slight improvement entails greater cost and inconvenience.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11955025     DOI: 10.7326/0003-4819-136-8-200204160-00006

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  153 in total

1.  Targeting people with pre-diabetes.

Authors:  K M Venkat Narayan; Giussepina Imperatore; Stephanie M Benjamin; Michael M Engelgau
Journal:  BMJ       Date:  2002-08-24

Review 2.  Low high-density lipoprotein cholesterol: physiological background, clinical importance and drug treatment.

Authors:  Martin Hersberger; Arnold von Eckardstein
Journal:  Drugs       Date:  2003       Impact factor: 9.546

3.  Population-based stepwise screening for unrecognised Type 2 diabetes is ineffective in general practice despite reliable algorithms.

Authors:  J O Christensen; A Sandbaek; T Lauritzen; K Borch-Johnsen
Journal:  Diabetologia       Date:  2004-09-08       Impact factor: 10.122

Review 4.  Impact of postprandial glycaemia on health and prevention of disease.

Authors:  E E Blaak; J-M Antoine; D Benton; I Björck; L Bozzetto; F Brouns; M Diamant; L Dye; T Hulshof; J J Holst; D J Lamport; M Laville; C L Lawton; A Meheust; A Nilson; S Normand; A A Rivellese; S Theis; S S Torekov; S Vinoy
Journal:  Obes Rev       Date:  2012-07-11       Impact factor: 9.213

Review 5.  Lifestyle interventions in preventing new type 2 diabetes in Asian populations.

Authors:  Pietro Amedeo Modesti; Giorgio Galanti; Piergiuseppe Cala'; Maria Calabrese
Journal:  Intern Emerg Med       Date:  2015-10-16       Impact factor: 3.397

6.  A case series: evaluation of the metabolic safety of aripiprazole.

Authors:  Marc De Hert; Linda Hanssens; Ruud van Winkel; Martien Wampers; Dominique Van Eyck; Andre Scheen; Joseph Peuskens
Journal:  Schizophr Bull       Date:  2006-08-29       Impact factor: 9.306

Review 7.  The impact of new guidelines for glucose tolerance testing on clinical practice and laboratory services.

Authors:  Andrew W Lyon; Erik T Larsen; Alun L Edwards
Journal:  CMAJ       Date:  2004-10-26       Impact factor: 8.262

8.  Strategies to identify adults at high risk for type 2 diabetes: the Diabetes Prevention Program.

Authors: 
Journal:  Diabetes Care       Date:  2005-01       Impact factor: 19.112

Review 9.  Epidemiology of the insulin resistance syndrome.

Authors:  James B Meigs
Journal:  Curr Diab Rep       Date:  2003-02       Impact factor: 4.810

10.  The relative importance of modifiable potential risk factors of type 2 diabetes: a meta-analysis of two cohorts.

Authors:  Maarit A Laaksonen; Paul Knekt; Harri Rissanen; Tommi Härkänen; Esa Virtala; Jukka Marniemi; Arpo Aromaa; Markku Heliövaara; Antti Reunanen
Journal:  Eur J Epidemiol       Date:  2009-12-13       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.